DEERFIELD BEACH, FL / ACCESSWIRE / January 30, 2017 / Digital payment processing is an emerging, growing market, with China and the US leading the market in terms of volume. It is growing at a tremendous rate compared to other forms of payments and money transfers, as the following chart shows:

Source – Statista

In order to cash in on the running trend, major and minor technology and financial services companies have floated their own wallets. However, the processing of these payments is key, and here, a small company called Payment Data Systems Inc. (NASDAQ: PYDS) is making some splash.

Payment Data Systems is a key player in this segment, as it provides integrated electronic payment processing services to merchants and businesses.

The company has been making progress with several of its plans. One of the most promising happenings in recent times is the company’s new collaboration with Applied Business Software Inc. The two companies plan to work together on various fronts, including use of ACH module for the purpose of making electronic payments and for online payment processing of credit cards, debit cards, and checks. The processing of checks, especially, is very important because it reaches an untapped segment of the market.

Applied Business Software develops software for loan servicing and other financial services. Its lead product, The Mortgage Office, is considered to be one of the leading software solutions in the lending industry. The deal helps in unlocking a new revenue market for Payment Data Systems.

CEO and President Louis Hoch said that PYDS can now explore the new market vertical of consumer mortgage loan servicing software and further diversify its customer base. With continued growth in the economy following the new President’s accession, the consumer mortgage sector is expected to be on an upswing. With the increase in mortgage volume, the demand for more efficient processing systems is also expected to increase. Payment Data Systems can leverage the deal to gain more expertise in this booming sector, which may further help it in diversifying its revenue streams.

The company also saw some restructuring in its upper management. Habib Yunus, the CFO of Payment Data Systems, announced his departure from the firm. He was at the helm of the company for nearly 22 months. He was replaced with recently appointed board member Tom Jewell.

Prior to this reshuffling, the company had appointed its founder Hoch as its new CEO in November last year. Change in top management signals that the company is now ready to explore new areas and shake up its operations.

However, the shakeup also led to some legal issues, as earlier this month, the company received a notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from NASDAQ. The company reported that on January 11, 2017, it received a letter from the Listing Qualifications staff of The Nasdaq Stock Market LLC, notifying it that the company is not in compliance with Nasdaq Listing Rule 506.

According to that rule, the company is required to have a majority of independent directors on its board of directors and an audit committee consisting of at least three independent audit committee members, one of whom must have “financial sophistication,” as evidenced by past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background.

On January 6, 2017, Tom Jewell resigned as a member of the company’s board of directors and audit committee, as he was appointed the company’s Chief Financial Officer. Jewell was inducted in the board late last year. Consequent to his appointment as the CFO, as of January 6, 2017, the board of directors consists of two independent directors and two employee directors and the audit committee consists of two independent members.

Another board member, Mr. Long, resigned as the company’s Chief Executive Officer effective August 4, 2016. Though he remained Chairman of the board of directors, he is not considered independent under the Nasdaq Listing Rules because of his recent employment with the Company.

The company notified NASDAQ of this shortcoming on January 6th, 2017. The company needs to make up the deficiency by the earlier of its next annual shareholders’ meeting or January 6, 2018; or if the next annual shareholders’ meeting is held before July 5, 2017, no later than July 5, 2017.

However, the issue should not cause much concern to prospective investors, as the company seems to be fully capable of rectifying the situation within the given time frame. Payment Data Systems said that it is currently in the process of interviewing potential candidates.

The payment processing industry is fast evolving amid the introduction of new cutting edge technologies. The use of technology has also made this segment highly competitive. Payment Data Systems needs to remain nimble to make the best of its resources. Its new collaboration with Applied Business is expected to help the company in further sharpening its technological edge.

Payment Data Systems had suffered operating loss in its third quarter. The main reason behind the loss was the charging of one-time items. However, the company needs to remain cautious as its operating margin remains under pressure. The company’s stress on increasing its revenue may further strain the margin, however, this is expected to be made up through higher revenue received from new deals.

The company stock had a choppy start this year as it tumbled down to lose more than 10 percent of its value this year so far. However, with the latest happenings, it is expected to regain its upward momentum. The company hopes the new collaboration will help it in boosting its topline and the stock price.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance, or achievements expressed or implied by such statements. WFM, Inc. is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. WFM, Inc. may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. WFM, Inc. may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://wwfinancial.com/legal-disclaimer/.

Contact:

WFM, Inc.
Phone: 954.360.9998

SOURCE: WFM, Inc.

ReleaseID: 453844

IRVINE, CA / ACCESSWIRE / January 30, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Rent-A-Center, Inc. (“Rent-A-Center” or the “Company”) (Nasdaq: RCII). Investors who purchased or otherwise acquired Rent-A-Center shares between July 27, 2015 and October 10, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the February 27, 2017 lead plaintiff deadline.

If you purchased shares of Rent-A-Center during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

In particular, the Company failed to reveal: that it was unable to install its new point of sale system (“POS”); that, the POS was not performing as intended and experienced system outrages; that because of this, the Company’s Acceptance Now credit system was not installed properly; that the Company was unable to meet revenue and profit guidance given to investors; that, as such, the Company needs to review its prior guidance; and that, due to the above, the Company’s statements about Rent-A-Center’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

When this information was revealed to the public, the value of Rent-A-Center fell, causing investors serious harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453836

CARSON CITY, NV / ACCESSWIRE / January 30, 2017 / Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that, in its efforts to better concentrate on upcoming observational clinical studies while simultaneously continuing the development of eBalance devices, the Company decided to divest one of its wholly-owned subsidiaries, Avyonce Cosmedics Inc. (“Avyonce”). Avyonce’s main business activity is the marketing and distribution of spa technologies.

Ms. Jean Arnett, a Director and Vice President, Corporate Development of Cell MedX, has chosen to continue her work with Avyonce to further develop its business model, and so, effective January 23, 2017, resigned from her management and directorship positions with Cell MedX. Cell MedX will transfer Avyonce to Ms. Jean Arnett for nominal consideration.

Cell MedX has appointed Bradley Hargreaves to its Board of Directors to fill the vacancy created by Ms. Arnett’s resignation. Mr. Hargreaves has acted as Cell MedX’s Vice President, Technology and Operations since November 2014. Ms. Arnett is the wife of Mr. Hargreaves.

The Company would like to thank Ms. Arnett for her contribution to Cell MedX and wishes her continued success spearheading Avyonce.

About Cell MedX Corp.

Cell MedX Corp. is an early development stage bio-tech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson’s disease, and high blood pressure. For more information about the Company and its technology, please visit our website at: www.cellmedx.com. For the Company’s newsletter, please go to www.cellmedx.com/media/newsletters/.

On behalf of the Board of Directors of Cell MedX Corp.

Frank McEnulty
Chief Executive Officer and President

Forward-Looking Statements

The information included in this press release has not been reviewed by the FDA, nor has it been peer reviewed. This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and assumptions and are identified by words such as “expects,” “intends,” “estimates,” “projects,” “anticipates,” “believes,” “could,” and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company’s Quarterly, Annual, and Current Reports filed with the United States Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company’s forward-looking statements. In particular, the Company’s eBalance technology is still in development. Except as required by law, Cell MedX Corp. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission, or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Cell MedX Corp. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.

For further information, visit: www.cellmedx.com
Or phone: 1-844-238-2692

SOURCE: Cell MedX Corp.

ReleaseID: 453845

IRVINE, CA / ACCESSWIRE / January 30, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Investors who purchased or otherwise acquired PlasmaTech Biopharmaceuticals, Inc. shares between March 31, 2015 and June 19, 2015; and/or Abeona shares between June 22, 2015 and December 9, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the February 14, 2017 lead
plaintiff motion deadline.

If you purchased shares of Abeona during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Mako Research published a report on SeekingAlpha.com stating, “ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure.” The report found that Steven H. Rouhandeh, the Company’s Executive Chairman and Principal Executive Officer, was once the managing director at D. Blech & Co., a brokerage firm that was the subject of SEC investigations during the 1990s, as well as a securities class action suit that ended in a $15 million investor settlement because of claims that the firm changed the price of some biotech stocks through transactions that falsely inflated the market price of the stocks.

When this information was released to the investing public, the value of Abeona fell sharply, causing investors serious harm.

If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453834

Mexico-Based Vacation Club Provides Underprivileged Children
the Opportunity to Enjoy a First Vacation

MONTEREY, MEXICO / ACCESSWIRE / January 30, 2017 / The Royal Holiday Foundation was launched in 2014 by the Royal Holiday Vacation Club with the goal of providing underprivileged children with the opportunity to enjoy their first vacation. This service is provided through week-long camps sponsored by the Royal Holiday Foundation in conjunction with Colonias de Vacaciones, a private assistance institutions that has provided children with life-changing experiences through vacations for over 50 years. Royal Holiday Foundation has pledged all of the donations they receive to Colonias de Vacaciones.

The first Royal Holiday Foundation camp was held in December 2014 in Tenancingo, Hidalgo (Estado de México) at an ex-hacienda, with 87 children in attendance. At the second Royal Holiday Foundation camp, held in 2016, 130 children participated. The foundation’s director, Concha León Portilla, said, “It’s a pleasure to work with Colonias de Vacaciones. It’s about helping fulfill the dream that many underprivileged kids have of experiencing a vacation. After seeing the first camp’s success, we felt like treating 130 children to a vacation, probably the only one they have taken in their life.”

To date, 480 children have participated in camping vacations in Tenancingo, Hidalgo sponsored by the Royal Holiday Foundation. The goal of the Royal Holiday Foundation is to increase sponsorship to 1,200 people per year, including children and adults, in order to provide 6,000 people with their first vacation experience over the course of five years.

Donations can be made at: vacationsarightforall.org

About Royal Holiday Foundation: The Royal Holiday Foundation was started in 2014 by the Royal Holiday Club, a Mexico-based vacation club that operates in 52 countries on six continents (North America, South America, Africa, Europe, and Asia) and has over 100,000 members.

The Royal Holiday
Foundation was created with the purpose of raising funds to sponsor underprivileged children to have their first vacation experience. The foundation’s slogan is “Everybody has the right to a vacation” and they started the “Vacations a right for all” movement.

Contact Information:

Royal Holiday Vacation Club/ Royal Holiday Foundation

Royal Holiday Vacation Club Phone: (81) 5980-1140

Royal Holiday Vacation Club Sales Office: monterrey@royal-holiday.com

Royal Holiday Foundation Information: fundacion@royal-holiday.com

SOURCE: Royal Holiday Vacation

ReleaseID: 453769

IRVINE, CA / ACCESSWIRE / January 30, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Investors, who purchased or otherwise acquired PlasmaTech Biopharmaceuticals, Inc. shares between March 31, 2015 and June 19, 2015; and/or Abeona shares between June 22, 2015 and December 9, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the February 14, 2017 lead plaintiff motion deadline.

If you purchased shares of Abeona during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Mako Research published a report on SeekingAlpha.com stating, “ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure.” The report found that Steven H. Rouhandeh, the Company’s Executive Chairman and Principal Executive Officer, was once the managing director at D. Blech & Co., a brokerage firm that was the subject of SEC investigations during the 1990s, as well as a securities class action suit that ended in a $15 million investor settlement because of claims that the firm changed the price of some biotech stocks through transactions that falsely inflated the market price of the stocks.

When this information was released to the investing public, the value of Abeona fell sharply, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453833

LOS ANGELES, CA / ACCESSWIRE / January 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against New Oriental Education & Technology Group Inc. (“New Oriental” or the “Company”) (NYSE: EDU). Investors, who purchased or otherwise acquired New Oriental shares between September 27, 2016 and December 1, 2016 inclusive (the “Class Period”), are encouraged to contact the firm prior to the February 13, 2017, also known as the lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Reuters published an article on December 2, 2016 revealing that New Oriental has been accused of engaging in college application fraud. The article states that “[e]ight former and current New Oriental employees…told Reuters the firms have engaged in college application fraud, including writing application essays and teacher recommendations, and falsifying high school transcripts.” That day, Reuters released an update stating that due to its earlier report detailing academic fraud allegations at New Oriental, the American International Recruitment Council (“AIRC”) stated that it “will investigate the company in response to the report,” and the AIRC’s president-elect referred to the allegations as “highly concerning.” When this information was revealed to the investing public, the value of New Oriental stock fell, causing investors harm.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 453832

NEW YORK, NY / ACCESSWIRE / January 30, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation (“Egalet”) (NASDAQ: EGLT) between December 15, 2015 and January 9, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Mineff v. Egalet Corporation, et al. (Case No. 2:17-cv-00390-MMB) in the USDC for the Eastern District of Pennsylvania. Click here to view the complaint. To get more information go to:

http://www.zlk.com/pslra/egalet-corporation

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materially false and/or misleading statements concerning its lead product, ARYMO ER and the likelihood the product would receive oral abuse-deterrent labeling.

Take Action: if you suffered a loss in Egalet you have until March 28, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 453838

VANCOUVER, BC / ACCESSWIRE / January 30, 2017 / Lomiko Metals Inc. (“Lomiko”) (TSXV: LMR) (OTCQB: LMRMF) (FSE: DH8C) wish to report an update to the trading status of Lomiko Metals. Lomiko has moved to the OTCQB and currently trades under the symbol LMRMF. In Germany, the WKN number is A2DJKB; and the Symbol: DH8C.

On January 17th, 2017, Lomiko announced high grade graphite results from the near surface Refractory zone at the La Loutre project of 7.74% graphite over 135.60 metres including 16.81% graphite over 44.10 metres from hole LL-16-01, two different intersection in hole LL-16-02 reporting 17.08% graphite over 22.30 metres, 14.80% graphite over 15.10 metres and 110.80 metres of 14.56% Graphite in Hole LL-16-03. A further 7 drill holes remain to be reported.

Refractory Zone Drill Map

To view an enhanced version of the Refractory Zone Drill Map, please visit: http://www.accesswire.com/uploads/24805_lomiko1enhanced.jpg

The company also wishes to clarify the names of the flake graphite zones at the La Loutre Flake Graphite Property.

The Graphene-Battery Zone is named for potential markets that may be developed for flake graphite but does not contain graphene or, of course, batteries in the ground. Further, the Refractory Zone does not refer to refractory ore, or to our knowledge, contain sulphides requiring specialized treatment. The name refers to graphite used in refractory bricks and for insulation in the steel-making industry.

For more information on Lomiko Metals, review the website at www.lomiko.com, contact A. Paul Gill at 604-729-5312 or email: info@lomiko.com.

On Behalf of the Board

“A. Paul Gill”
Chief Executive Officer

We seek safe harbor.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Lomiko Metals Inc.

ReleaseID: 453835

IRVINE, CA / ACCESSWIRE / January 30, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against General Cable Corporation (“General Cable” or the “Company”) (NYSE: BGC). Investors, who purchased or otherwise acquired shares between February 23, 2012 and February 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the March 6, 2017 lead plaintiff motion deadline.

If you purchased shares of General Cable during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

On February 10, 2016, General Cable stated that it could have incurred more than $33 million in profits through transactions violating the FCPA, an amount that would have to be disgorged, with interest. When this information was released to the investing public, the value of General Cable fell $3.05 per share or over 31.6% from its previous closing price to close at $6.60 per share on February 11, 2016.

The U.S. Department of Justice then issued the following statement: “[b]etween 2002 and 2013, General Cable subsidiaries paid approximately $13 million to third-party agents and distributors, a portion of which was used to make unlawful payments to obtain business, ultimately netting the company approximately $51 million in profits.” Upon the release of this information was released to the public, the value of General Cable fell sharply, causing investors serious harm.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453830